{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-077354","form_type":"8-K","ticker":"DFTX","cik":"0001813814","company_name":"Definium Therapeutics, Inc.","filed_at":"2026-06-24T21:14:45+00:00","discovered_at":"2026-06-24T21:16:00.318352+00:00","generated_at":"2026-06-24T21:16:23.379842+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Definium Therapeutics prices $805M public offering of 20.6M shares at $34 each, upsized from $700M","bullets":["Offering of 20,588,236 common shares at $34.00 per share, with full exercise of underwriters' 30-day option for additional 3,088,235 shares.","Gross proceeds ~$805M; net proceeds ~$758M after underwriting discounts and expenses.","Proceeds to fund R&D, commercialization preparation for DT120 ODT if approved, and working capital.","Underwriters: J.P. Morgan, Jefferies, Leerink, BofA, Evercore ISI, Stifel, Oppenheimer, LifeSci.","Expected close June 25, 2026; 60-day lock-up for directors, officers, and company."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-077354","json":"https://secwatch.observer/filing/0001104659-26-077354.json","markdown":"https://secwatch.observer/filing/0001104659-26-077354.md","text":"https://secwatch.observer/filing/0001104659-26-077354.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1813814/000110465926077354/0001104659-26-077354-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1813814/000110465926077354/tm2618395d3_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T21:16:23.379842+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}